MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuro-Oncology

• Publication date

  2012-04-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/nos074PMID 22492962PMCID PMC3367845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126.

  2012cited by this paper
• Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.

  2012cited by this paper
• Novel approaches to treating leptomeningeal metastases

  2011cited by this paper
• Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.

  2011cited by this paper
• Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

  2011cited by this paper
• Survey of MicroRNA expression in pediatric brain tumors

  2011cited by this paper
• Human glioma growth is controlled by microRNA-10b.

  2011cited by this paper
• Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

  2011cited by this paper
• MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4

  2011cited by this paper
• The microRNA spectrum in 12 body fluids.

  2010cited by this paper
• Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

  2010cited by this paper
• Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

  2010cited by this paper
• MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

  2009cited by this paper
• miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments

  2009cited by this paper
• MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC

  2009cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers

  2008cited by this paper
• miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

  2008cited by this paper
• The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis

  2008cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

  2008cited by this paper
• Serum MicroRNAs Are Promising Novel Biomarkers

  2008cited by this paper
• MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

  2008cited by this paper
• miR-21: a small multi-faceted RNA

  2008cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors

  2008cited by this paper
• Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.

  2008cited by this paper
• Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

  2008cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• Characterization of microRNA expression profiles in normal human tissues

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• BMC Genomics BioMed Central

  2007cited by this paper
• Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.

  2006cited by this paper
• Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

  2006cited by this paper
• Profiling alternatively spliced mRNA isoforms for prostate cancer classification

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Extensive modulation of a set of microRNAs in primary glioblastoma.

  2005cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper

• The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma.

  2026cites this paper
• Exploring CSF microRNA signatures as diagnostic biomarkers in adult-type diffuse gliomas

  2026cites this paper
• Diversity and function of tumor-associated macrophages in brain metastases: mechanisms and therapeutic prospects.

  2026cites this paper
• Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome

  2025cites this paper
• Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC‐Derived Neural Stem Cells and Floor Plate Progenitors

  2025cites this paper
• Advances of Artificial Intelligence in Clinical Application and Scientific Research of Neuro-oncology: Current Knowledge and Future Perspectives.

  2025cites this paper
• Extracellular vesicle-derived miR21 of non-tumoral origin as early diagnostic marker of glioma

  2025cites this paper
• Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

  2025cites this paper
• Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment

  2025cites this paper
• Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance

  2025cites this paper
• Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma

  2025cites this paper
• Brain metastasis in non‐small cell lung cancer: High‐risk factors and predictive models

  2025cites this paper
• The Quest for Non-Invasive Diagnosis: A Review of Liquid Biopsy in Glioblastoma

  2025cites this paper
• Exploring the Diagnostic Test Accuracy of MicroRNAs as Potential Biomarkers for Glioblastoma: Systematic Review and Meta-Analysis.

  2025cites this paper
• Machine learning models for brain tumors differential diagnosis

  2025cites this paper
• Circulating MicroRNAs do not provide a diagnostic benefit over tissue biopsy in patients with brain metastases

  2025cites this paper
• Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.

  2024cites this paper
• Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.

  2024cites this paper
• Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas

  2024cites this paper
• Extracellular Vesicles from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients Deliver MiR-21 and Induce Methotrexate Resistance in Lung Cancer Cells

  2024cites this paper
• Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study

  2024cites this paper
• Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms

  2024cites this paper
• Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas

  2024cites this paper
• Role of exosomes in diagnosis, prognostication, and treatment of pediatric solid tumors

  2024cites this paper
• MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis

  2024cites this paper
• Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

  2024cites this paper
• Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis

  2024cites this paper
• The Potential of Circulating Cell-Free RNA in CNS Tumor Diagnosis and Monitoring: A Liquid Biopsy Approach.

  2024cites this paper
• Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma

  2024cites this paper
• An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection

  2024cites this paper
• [Liquid biopsy in diagnosis of central nervous system tumors].

  2024cites this paper
• Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma

  2024cites this paper
• Exosomal circRNAs as promising liquid biopsy biomarkers for glioma

  2023cites this paper
• The Current Landscape of Glioblastoma Biomarkers in Body Fluids

  2023cites this paper
• A review of recent advances in the molecular mechanisms underlying brain metastasis in lung cancer.

  2023cites this paper
• Exploring the role of cerebrospinal fluid as analyte in neurologic disorders

  2023cites this paper
• Molecular mechanisms of microRNAs in glioblastoma pathogenesis.

  2023cites this paper
• Non-coding RNA’s prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer

  2023cites this paper
• Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma

  2023cites this paper
• Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers

  2023cites this paper
• microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review

  2023cites this paper
• Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers

  2023influential citation
• Role of miR‑200 family in brain metastases: A systematic review

  2023cites this paper
• Gamma Knife Radiosurgery Modulates micro-RNA Levels in Patients with Brain Metastasis.

  2023cites this paper
• Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors

  2023cites this paper
• Recent advances in label-free optical, electrochemical, and electronic biosensors for glioma biomarkers.

  2023cites this paper
• Liquid biopsy: creating opportunities in brain space

  2023cites this paper
• CSF Biopsy in Glioma: A Brief Review.

  2023cites this paper
• Liquid biomarkers in glioma

  2023cites this paper
• Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility

  2022cites this paper
• Electrochemical biosensing of circulating microRNA-21 in cerebrospinal fluid of medulloblastoma patients through target-induced redox signal amplification

  2022cites this paper
• MicroRNAs as prognostic markers and therapeutic targets in gliomas

  2022cites this paper
• Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases

  2022cites this paper
• Liquid biopsy: early and accurate diagnosis of brain tumor

  2022cites this paper
• Advances in the Diagnosis and Treatment of Leptomeningeal Disease

  2022cites this paper
• Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer

  2022cites this paper
• Micro-ribonucleic acids (miRNAs) and a proteomic profile in lung adenocarcinoma cases with brain metastasis

  2022cites this paper
• Thioredoxin system and miR-21, miR-23a/b and let-7a as potential biomarkers for brain tumor progression: Preliminary Case Data.

  2022cites this paper
• Tumor-derived Biomarkers in Liquid Biopsy of Glioblastoma.

  2022cites this paper
• Liquid biopsy: the value of different bodily fluids.

  2022cites this paper
• A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy

  2022cites this paper
• The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas

  2022cites this paper
• The role of liquid biopsy in the diagnosis of glioblastoma progression

  2022cites this paper
• miR-497 and 219 in blood aid meningioma classification

  2022cites this paper
• Machine learning and bioinformatics approaches for classification and clinical detection of bevacizumab responsive glioblastoma subtypes based on miRNA expression

  2022cites this paper
• Role, Significance, and Association of MicroRNA-10a/b in Physiology of Cancer.

  2022cites this paper
• Assessment and prediction of glioblastoma therapy response: challenges and opportunities.

  2022cites this paper
• Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives

  2021cites this paper
• Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors

  2021cites this paper
• Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy

  2021cites this paper
• Precision Oncology, Signaling and Anticancer Agents in Cancer Therapeutics.

  2021cites this paper
• The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions

  2021cites this paper
• miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients

  2021cites this paper
• Cerebrospinal fluid as a medium of liquid biopsy in the management of patients with non-small-cell lung cancer having central nervous system metastasis.

  2021cites this paper
• Noncoding RNAs regulate alternative splicing in Cancer

  2021cites this paper
• Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia–Glioma Cross-Talk

  2021cites this paper
• Preliminary Study of hsa-mir-626 Change in the Cerebrospinal Fluid in Parkinson's Disease.

  2021cites this paper
• Liquid biopsy in gliobastoma management: from current research to future perspectives.

  2021cites this paper
• Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease

  2021cites this paper
• Evolving Landscape of Long Non-coding RNAs in Cerebrospinal Fluid: A Key Role From Diagnosis to Therapy in Brain Tumors

  2021cites this paper
• Prognostic and Predictive Biomarkers in Gliomas

  2021cites this paper
• Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses

  2021cites this paper
• Epigenetics and doping in sports—The role of microRNAs

  2021cites this paper
• Circulating Biomarkers in Glioblastoma: Ready for Prime Time?

  2021cites this paper
• Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.

  2021cites this paper
• Role of miRNAs In Cancer Diagnostics And Therapy: A Recent Update.

  2021cites this paper
• Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs

  2021cites this paper
• A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.

  2021cites this paper
• A nuclear function for an oncogenic microRNA as a modulator of snRNA and splicing

  2021cites this paper
• MicroRNAs: emerging driver of cancer perineural invasion

  2021cites this paper
• Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers

  2021influential citation
• Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis

  2021cites this paper
• Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge

  2021cites this paper
• MiR-200c-based metabolic modulation in glioblastoma cells as a strategy to overcome tumor chemoresistance.

  2021cites this paper
• Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.

  2020cites this paper
• Brain Tumor-Derived Extracellular Vesicles as Carriers of Disease Markers: Molecular Chaperones and MicroRNAs

  2020cites this paper
• Circulating microRNAs as Potential Biomarkers in Glioma: A Mini Review.

  2020cites this paper
• Serum microRNA is a biomarker for post-operative monitoring in glioma

  2020cites this paper
• Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis

  2020cites this paper
• The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?

  2020cites this paper